August 12, 2014
Stories this photo appears in:
Cytori Therapeutics Inc. announced that it has completed the sale of shares of its Series A 3.6 percent convertible preferred stock pursuant to a registered direct offering representing gross proceeds of about $13.5 million.
Cytori Therapeutics, a cell therapy company in San Diego, announced an updated strategy and plan to restructure its operations and reduce costs.
San Diego-based Cytori Therapeutics Inc. announced that Tiago Girão has been appointed vice president and chief financial officer.
Cytori Therapeutics Inc. reported a net loss of $11.8 million for second quarter 2014, down from a net loss $3.2 million during the same period in 2013.